VDR polymorphisms influence immunological response in HIV-1+ individuals undergoing antiretroviral therapy
AUTOR(ES)
Silva, Ronaldo Celerino da
FONTE
Genet. Mol. Biol.
DATA DE PUBLICAÇÃO
27/06/2019
RESUMO
Abstract Vitamin D exerts an immuno-modulatory activity on several immune system cells through the vitamin D receptor (VDR). Herein, we verified that age and a therapeutic regimen containing protease inhibitors are associated with failures in antiretroviral therapies (ARVs). In addition, we assessed whether a VDR SNP (rs11568820: C allele and CC genotype) and GC (rs2228570-rs11568820) allelic combinations are associated with immunological failure (p < 0.05). Our findings suggest a possible role of VDR SNPs on immunological failure in HIV-1+ individuals undergoing regular ARVs.
Documentos Relacionados
- Potentiation of the immune response in HIV-1+ individuals.
- Different nutritional-state indicators of HIV-positive individuals undergoing antiretroviral therapy
- Effect of soluble fiber on hypertriglyceridemia and immune profile in HIV-positive individuals undergoing highly active antiretroviral therapy
- Response of HIV-associated proteinuria to antiretroviral therapy in HIV-1-infected children
- Langerhans cells in periodontal disease of HIV- and HIV+ patients undergoing highly active antiretroviral therapy
